Follow-The-Filings

Security · featured owners

CCCC C4 Therapeutics Inc.

Health Care COM STK Equity as of 2026 Q2 among managers we track

  • 1 exit

CCCC (C4 Therapeutics Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 28,000 $74K History

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
424B5 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Sep 18, 2026 Filing Doc
4 Period Jul 10, 2026 Filing Doc
4 Period Jul 1, 2026 · 2 forms Filing Doc
4 Period Jun 24, 2026 · 8 forms Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period Apr 1, 2026 · 2 forms Filing Doc
4 Period Feb 13, 2026 · 7 forms Filing Doc
4 Period Jan 16, 2026 Filing Doc
4 Period Jan 2, 2026 · 2 forms Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $20.76M $35.58M $35.95M
Net income -$132.49M -$105.32M -$104.99M
Net margin * -638.3% -296.0% -292.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $271.19M $257.77M $258.11M
Total non-current assets * $105.26M $91.84M $100.96M
Total assets $376.45M $349.6M $359.08M
Total current liabilities $42.77M $45.18M $33.03M
Total non-current liabilities * $87.57M $88.44M $69.46M
Total equity $246.11M $215.99M $256.59M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$106.84M -$65.16M -$98.69M
Cash from investing $158.35M -$51.27M -$8.6M
Cash from financing $45.49M $45.34M $126.4M
Net change in cash $97M -$71.09M $19.1M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders